Analyst picks & changes

Guilford Pharmaceuticals Inc.

(GLFD)

Franklin Berger of Josephthal, Lyon & Ross began coverage with a "buy" and a one year price target of $8.50. He

Read the full 257 word article

How to gain access

Continue reading with a
two-week free trial.